Search Results 231-240 of 17225 for hba1c

1. https://www.mayoclinic.org/chinese_patient_consumer_recipe.xml

2. Diabetes - Doctors and departments - Mayo Clinic

   Learn more about the different types of this blood sugar disorder, who's at risk and how each type can be treated.

3. Fuchs' Dystrophy Clinical Trials - Mayo Clinic Research

   ... (HbA1c), and skin advanced glycation endproducts (AGE) and ... . Mayo Clinic Footer. Request Appointment · Give Now · Contact Us · About Mayo Clinic · Employees ...

4. Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis - Mayo Clinic

   Subjects with uncontrolled diabetes, as defined by HbA1c > 7%. 9. Subjects who have used the following medications: - Methotrexate within 90 days of ...

5. A Study To Evaluate The Effectiveness And Safety Of Elafibranor For Patients With Nonalcoholic Fatty Liver Disease - Mayo Clinic

   Decompensated diabetes (HbA1c>9%); A history of clinically significant acute cardiac event within 6 months prior to screening; Weight loss of more than 5 ...

6. The BROADEN Study: A Study Of Volanesorsen (Formerly ISIS-APOCIIIRx) In Patients With Familial Partial Lipodystrophy - Mayo Clinic

   Diabetes not well controlled on antidiabetic therapy with HbA1c ≥ 7% to ≤ 12% at Screening; Hypertriglyceridemia with Fasting TG levels ≥ 500 mg/dL ...

7. Linagliptin and metformin (oral route) - Side effects & dosage - Mayo Clinic

   Linagliptin helps to control blood sugar levels by increasing substances in the body that make the pancreas release more insulin. It also signals the liver to ...

8. A Study To Evaluate The Effectiveness And Safety Of Brolucizumab Vs. Aflibercept In Patients With Visual Impairment Due To Diabetic Macular Edema - Mayo Clinic

   Patients with type 1 or type 2 diabetes mellitus (DM) and Hemoglobin A1c (HbA1c) ≤ 12% at screening. Study eye: Visual impairment due to DME with: Best ...

9. A Study To Evaluate The Safety And Efficacy Of CT1812 In Early Alzheimer's Disease - Mayo Clinic

   Uncontrolled diabetes defined by HbA1c >7.5. 11. History of cancer within 3 years of screening with the exception of fully excised non-melanoma skin cancers ...

10. Pasireotide LAR In Severe Polycystic Liver Disease - Mayo Clinic

    Patients who have Uncontrolled diabetes as defined by HbA1c>8%* despite adequate therapy; Patients with the presence of active or suspected acute or chronic ...